Deep reading of "two vote system" | "the first vote" is the key to the choice and challenge of opening high

Source: the discussion on "two vote system" in the pharmaceutical economic news 2016-04-21 has become increasingly hot At present, most enterprises adopt the mode of bottom price investment promotion, and the implementation of "two vote system" is bound to bring challenges to the financial ability, management ability and marketing mode of enterprises In addition, for the critical "first vote", industrial enterprises need to be more cautious and choose a suitable business company as a partner Then, commercial companies that can provide compliant expense invoices and have a full team, strong academic promotion, commercial agency and commercial distribution capabilities will become the first choice of industrial enterprises The impact of the "two vote system" on the pharmaceutical industry depends on the strength of national implementation According to Yan Zheng, vice chairman of Jiangsu Wuzhong Industry Co., Ltd., "it is preliminarily planned to implement it in pilot cities now, but how to do it, such as what measures will be taken by the enterprises implementing the" two vote system "and the enterprises not implementing it under the same environment, all of which need to be concerned "The two vote system" has been discussed for a long time, but Fujian Province is the only one that has really implemented and achieved relatively good results " "For enterprises with terminal teams, there is no problem in implementing the" two vote system " In the past, foreign enterprises and mainstream large enterprises have done so Moreover, large enterprises can also carry out strategic cooperation with large commercial companies In addition, exclusive varieties do not need bottom price investment, because the enterprise has cost space to build its own team Therefore, some small enterprises are hard to build their own teams in the country due to the fierce competition of varieties, so they only adopt the mode of bottom price investment promotion " Yan said It is worth noting that after the implementation of the "two vote system", the original bottom price billing pharmaceutical companies may switch to high opening After the high opening, sales revenue and tax payment will increase significantly Enterprises need to think about how to digest the increased tax after the high opening Some experts pointed out that most enterprises may not have enough ability to deal with the costs caused by high development "I really hope to implement the" two vote system " On the one hand, the sales volume of enterprises can be increased, on the other hand, the tax revenue will be increased, and the local government is happy." The person in charge of the above-mentioned enterprise pointed out that after the implementation of the "two vote system", the enterprise's ability to control prices has been enhanced In fact, the price difference between the same drug in the bidding system and the actual billing is very large For a long time, the state has required to check the factory price If the final price is checked and invoiced, then only that price can be sold Therefore, the enterprise hopes to make a high invoice The main problem is that the agents, because they low invoice, and then go outside "walk ticket", the profit space than the regular manufacturers to give more space In particular, individual agents or small agents, high billing makes their profit space smaller Therefore, there is a game between industry and commerce At present, there are many pharmaceutical manufacturers, with serious homogeneous competition Rao Yuanli, an associate professor at the school of economics and management of Guangzhou University of traditional Chinese medicine, told reporters: "under the implementation of the" two vote system ", enterprises may face reshuffle Moreover, after the implementation of the "two vote system", it will take some time for enterprises to observe how to attract investment However, it needs to be clear that certain profit space should be left for pharmaceutical enterprises to develop, so profits and expenses among hospitals, pharmaceutical enterprises and patients should be reasonably distributed and borne " In addition, some insiders pointed out that the implementation of the "two vote system" may subvert the marketing settlement mode of pharmaceutical enterprises, and the base price agency system is bound to become a history, turning to the commission agency mode To find the right commercial enterprises at the national level, the "two vote system" can make the drug price transparent, the space more reasonable, and also help the pharmaceutical marketing, marketing and academic promotion become more standardized In the view of the industry, the most important task for industrial enterprises is to choose a suitable commercial company to issue the "first ticket" Moreover, due to the high cost, it is impossible for industrial enterprises to directly distribute to county-level companies in each province, which requires commercial companies to have terminal networks that meet the industrial needs During the interview, some business people told reporters that for industrial enterprises, after "replacing business tax with value-added tax", regular invoices, including marketing, service and advertising expenses, can be deducted from tax The problem is still that the agents, the enterprises that issue the base price invoices, should turn into high-level ones, and the businesses must obey the principle of "replacing business tax with value-added tax", and then issue legal value-added tax invoices for the industry to reimburse the expenses The key is that industry and Commerce have increased the cost of tax payment, so the profit space has become smaller, and where the invoice comes from, especially for small agents, who need terminal promotion costs, how to get a compliant business invoice is the most difficult for them According to Yan Zheng, "if a commercial company fails to operate, it will also have an impact on industrial sales, which is also a process of business reshuffle Only a standardized commercial company will have more opportunities to represent the high-quality products of industrial enterprises, and only a regular commercial company can issue legal invoices to enterprises." In the view of the industry, industrial enterprises will definitely choose commercial companies with good reputation, complete team, academic promotion, commercial agency and commercial distribution capabilities Small agents, especially those at the county level, may have less direct cooperation with industrial enterprises in the future Because individual agents can not meet the manufacturer's specifications Therefore, the formal invoice and standardized operation will be specified in the agency contract in the future Small businesses may become internal partners of primary and secondary agents.